Hollencrest Capital Management Makes New Investment in Humana Inc. (NYSE:HUM)

Hollencrest Capital Management bought a new stake in shares of Humana Inc. (NYSE:HUM) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm bought 107 shares of the insurance provider’s stock, valued at approximately $40,000.

Other large investors also recently added to or reduced their stakes in the company. CarsonAllaria Wealth Management Ltd. grew its stake in shares of Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock valued at $28,000 after buying an additional 39 shares during the last quarter. Hantz Financial Services Inc. bought a new position in Humana during the 2nd quarter worth approximately $35,000. Family Firm Inc. purchased a new position in Humana in the 2nd quarter worth approximately $37,000. Riverview Trust Co bought a new stake in Humana in the second quarter valued at approximately $44,000. Finally, Carolinas Wealth Consulting LLC lifted its position in Humana by 274.1% in the fourth quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock valued at $46,000 after purchasing an additional 74 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on HUM. Oppenheimer lifted their target price on shares of Humana from $370.00 to $400.00 and gave the stock an “outperform” rating in a research note on Thursday, August 1st. Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Humana from $341.00 to $349.00 and gave the company a “hold” rating in a research report on Friday, August 2nd. Cantor Fitzgerald reiterated a “neutral” rating and set a $395.00 target price on shares of Humana in a report on Friday. Robert W. Baird began coverage on Humana in a report on Thursday, May 30th. They set a “neutral” rating and a $374.00 price target on the stock. Finally, Piper Sandler initiated coverage on Humana in a report on Wednesday, June 26th. They issued an “overweight” rating and a $392.00 price objective for the company. Thirteen research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $398.70.

Humana Price Performance

HUM stock opened at $310.41 on Friday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.66 and a current ratio of 1.66. The firm has a 50 day moving average price of $357.71 and a 200-day moving average price of $345.63. Humana Inc. has a 52-week low of $298.61 and a 52-week high of $530.54. The firm has a market capitalization of $37.40 billion, a price-to-earnings ratio of 19.33, a PEG ratio of 2.56 and a beta of 0.50.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. Humana had a return on equity of 16.12% and a net margin of 1.53%. The business had revenue of $29.54 billion during the quarter, compared to analysts’ expectations of $28.52 billion. During the same quarter in the previous year, the business earned $8.94 earnings per share. The firm’s quarterly revenue was up 10.4% compared to the same quarter last year. Equities research analysts forecast that Humana Inc. will post 16 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 25th. Shareholders of record on Monday, September 30th will be paid a dividend of $0.885 per share. The ex-dividend date is Monday, September 30th. This represents a $3.54 dividend on an annualized basis and a yield of 1.14%. Humana’s dividend payout ratio is currently 22.04%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.